Ladenburg Thalman

Ladenburg Thalmann downgraded Zosano Pharma Corp (NASDAQ: ZSAN) to Neutral from Buy as it prefers to remain on the sideline until the company improves its financial position and there is clarity of market opportunity for migraine treatment ZP-Triptan (now called M207). Zosano ended second...

Ladenburg Thalman is out with a research report this afternoon, where it reiterates its Neutral rating on Celsius Holdings (NASDAQ: CELH); it has a $0.40 price target on the stock, down from $0.80. The LT analysts said that they continue to believe that CELH's share price will be more event than...

Analysts at Ladenburg Thalman (AMEX: LTS) have released an update on the Financial Services industry, previewing the monthly credit card statistics for January. The credit card statistics for January are expected to be reported on February 16. Analysts expect higher delinquencies, and higher net...